Introduction
The majority (85 to 90%) of abortions performed in the first trimester 1 . There is still a gradual increase in second trimester abortion because of the progress achieved in the field of fetal antenatal diagnosis. Mid trimester, abortion is more risky in terms of maternal morbidity and mortality. It has moral, social, emotional and technical issues. 2 In the interest of mother's health and life under the MTP Act, mid trimester abortion performed by surgical or medical methods. Surgical method is loosing its popularity due to its inherent complications, need trained individuals and equipments and the advantages offered by medical methods. Now adays, majority of mid trimester abortions carried out medically. There are various medical regimes with variable success rates and complications. 3 PGE 1 analogue Misoprostol has uterotonic effect and is used for the termination of pregnancy with great success. Misoprostol acts by causing cervical ripening and labour induction. 4 Ethacridine lactate has a long history of use for mid-trimester abortion in our country. It works by endogenous production of prostaglandins by stripping of fetal membrane from the uterine decidua along with mechanical stimulation provided by catheter. 5 Ethacridine lactate is safe and effective method for mid trimester termination of pregnancy that nullify its disadvantage of prolonged induction-abortion interval. Simultaneous use of two different drugs has a synergistic effect on uterine stimulation and reduces the induction-abortion interval. In this study, comparison has been done regarding efficacy, safety and induction-abortion interval of intravaginal Misoprostol alone versus extra-amniotic Ethacridine lactate 0.1% instillation followed by intravaginal Misoprostol for mid-trimester (13-20 wks) termination of pregnancy. 
II. Material & Methods
60 women with valid legal indications as per MTP Act of India for mid-trimester abortion were studied in Mahila chikisalay, SMS Medical College, Jaipur. Gestational age was determined from last menstrual period, abdominal & bimanual examination and ultrasonography. Women having intrauterine fetal death, cervical dilatation more than 1 cm and length of cervix less than 3 cm, haemoglobin less than 8 gm%, low lying placenta, scarred uterus (previous caesarean section, previous hysterotomy / myomectomy), coagulation disorder, local vaginal lesion and multiple pregnancy were excluded from the study. Women selected by randomized method. Each group had 30 women. Group-A received intravaginal tab Misoprostol 600 g followed by 400 g 8 hourly vaginally and Group-B received extra-anminotic Ethacridine lactate 0.1% (10 ml/week of gestation, not more than 150 cc, using Foley's catheter inflated with 25cc normal saline) followed 6 hours later by vaginal tab Misoprostol 400 g 3 hourly until abortion occurred or upto 48 hours. Catheter expelled out spontaneously or removed after 24 hours.
Women observed for 48 hours for spontaneous expulsion of products. In our study if no expulsion occurred in 48 hours, the cases considered as failure. In both groups after delivery of fetus, all women received 20 units of oxytocin in 500 cc of 5% dextrose. When placenta and membranes expelled within 1 hour of expulsion of fetus, abortion considered as complete. If not, manual removal or curettage was done and the abortion was considered as incomplete. Induction-abortion interval was defined as time taken from initial instillation of drug to the complete expulsion of conceptus. Discharge of the patient was done after 24 hours of abortion, if she had no complaints. Success rate, induction-abortion interval, type of abortion, side effects and complications and hospital stay noted. Statistical analysis was done by using unpaired't' test where appropriate.
III. Results
Mean age of women in our study was 25 years. 91.67% cases were Hindu and 75% were literate. Most women came from urban areas (66.67%) with mean parity 1.51 (majority were Para 1 and Para 2) and mean gestational age 16.8 weeks. Main indication of MTP was on Medical grounds followed by Eugenic then Social grounds.In mean induction-abortion interval in Group-A was 24.9  10.83 hours and in Group-B it was 18.3  6.1 hours [P-value was 0.0063 statistically significant] (as shown in 
IV. Discussion
Ethacridine lactate for midtrimester abortion has a long history of use in our country and its safety has documented. There are no apparent contraindications for its use. Its use alone has certain disadvantages like longer induction abortion interval, higher failure rate and more chances of incomplete abortion. However, by combining Ethacridine lactate with tab Misoprostol per vaginally these disadvantages has largely overcome leading to shorter induction abortion time and higher success rates in terms of complete abortion. Hence, this regime is now better alternative for either agent used alone. Biswas Subhash Chandra, Dey Ramprasad et al (2007) 3 randomized 50 women for mid-trimester termination of pregnancy (13-20 weeks) in 2 groups. Group I -600 g Misoprostol was given vaginally followed by 400 g 8 hourly upto maximum 48 hours. In Group II -150 ml of Ethacridine was instilled extraamniotically. Misoprostol was found to be 92% effective as compared to Ethacridine with 80% effectiveness. Mean induction-abortion interval was 13.94 hours in Group I v/s 28.86 hours in Group II. In Group I 84% aborted within 24 hours and 92% within 36 hours whereas in Group II 16% aborted within 24 hours and 68% within 36 hours. 32% women in Group I and 44% in Group II experienced complications. Hence used alone, Misoprostol is safer, more effective and acceptable than Ethacridine for midtrimester pregnancy termination. Chaudhuri Snehamay et al (2006) 6 studied 120 women between 13 to 20 weeks seeking for termination of pregnancy. Women were randomized in 2 groups. In one group extraamniotic Ethacridine lactate (10 ml/week of gestation) instillation was done and in the other group, 400 g Misoprostol was inserted vaginally 12 hourly for a maximum of 4 doses. Rate of successful abortions within 48 hrs was 95% The rate of complete abortion was 66.6% for Misoprostol and 70% for ethacridine lactate. Side effects were uncommon and did not differ between the two groups. This study shows shorter mean abortion time on using Misoprostol 400 g 12 hourly than our study. This probably is due to the larger sample size studied by Chaudhuri Snehamay et al. Tayade SA et al (2011) 7 compared the efficacy of Misoprostol alone and Ethacridine lactate for first and second trimester abortions. 120 women desirous of MTP were randomized into two groups. In Group-A (n = 42) Ethacridine lactate 10 ml/wk was instilled extra-amniotically after adding 200 g Misoprostol to it followed by 200 g Misoprostol was inserted intravaginally 2 hourly upto 4 doses. Group-B (n = 78) received only 200 g Misoprostol intravaginally 2 hourly upto maximum 5 doses. Results of their study made conclusion that Misoprostol has the ability to interrupt pregnancy at any gestational age and addition of Ethacridine lactate enhances the efficacy of Misoprostol for first and second trimester induced abortion without undue complications. Prostaglandins when used with Ethacridine lactate have synergistic effect with endogenous prostaglandins released due to stripping of membranes from extra-amniotic Ethacridine lactate instillation.
V. Conclusion
Both Misoprostol alone or Ethacridine lactate with Misoprostol are effective in mid-trimester termination of pregnancy. Our study concludes that Ethacridine lactate followed by Misoprostol is more effective, safer, and with lesser side effects and complications, acceptable and has less induction-abortion interval than Misoprostol alone.So it should be the method of choice for mid-trimester termination of pregnancy. 
